Meetings of the Open Section frequently address themselves to ethical problems: this one explored the question of what research on children may be permitted. After a brief introduction by Dr R H Nicholson, Dr E Shinebourne (Consultant Paediatrician, Brompton Hospital, London) opened the subject with the statement that research is to be regarded as a good thing -that more research tends to make clinical practice more ethical, not less. He quoted the nineteenth-century French physiologist Claude Bernard: 'It i~our duty and our right to perform an experiment on man whenever it can save his life, cure him, or gain him some personal benefit', and then proceeded to examine in terms of this statement some of the ethical problems that research may pose, with particular reference to children.
Referring to the working group set up recently by the Institute of Medical Ethics, he remarked that one of its recommendations had been that research should not be undertaken on children unless there was no other reliable or relevant route to the same end. An analogous American institution had similarly recommended that, since research should be not haphazard but be 'a systematic investigation to increase the sum of know ledge', it must be scientifically both sound and significant: any committee concerned with ethical questions must have proper scientific advice. He then addressed himself to the moral complexities introduced by 'non-therapeutic' as opposed to therapeutic research, Therapeutic reo search implies a procedure involving a particular patient already suffering from a disease or malfunction, and he pointed out that in such cases it is the procedure (medical treatment, intervention, etc.) that may properly be regarded as 'therapeutic' rather than the research of which it may form a part: in the same sense nearly all clinical therapy is, in intention, 'therapeutic' though, lacking a research basis, much of it is often scientifically haphazard. 'Innovative therapy' usually implies that a new procedure is being employed, and it is generally agreed that in such cases the ratio of envisaged benefit to risk should be carefully weighed. The benefit side of the equation in a new method should be at least as great as that obtaining in established methods of treatment.
But the word 'benefit' shifts the discussion into the area of 'non-therapeutic research': benefit to whom? A conflict may arise between the likely benefit (if any) of a new procedure to an individual child and the putative good to other children. It is in the context of this moral dilemma that the subsidiary questions -What, with a child, may constitute 'informed consent'? Is 'proxy consent' by parents a valid concept? -also become particularly difficult. Doctors, by the nature of their own zeal, are inevitably apt to influence patients or patients' families: it is also undeniable that those involved in a research programme of innovative therapy stand to gain personal acclaim thereby, particularly with 'glamorous' procedures such as heart transplants.
To illustrate his earlier remarks, therefore, Dr Shinebourne outlined the recent history of treatment for transposition of the great arteries -the condition in which venous blood that should be reoxygenated bypasses the lungs, which then only receive already oxygenated blood: a 'blue baby' syndrome. Between 1970 and 1980 , treatment by what was known as Mustard's operation produced a mortality rate of 10% in the more straightforward cases, rising to 25% in cases complicated by a large aperture between the ventricles. A different operation, switching the major blood vessels, was introduced in 1976but at first had a Report of meeting of Open Section, 10 February 1986 0141-0768/87/ 050321·03/$02.00/0 e 1987 The Royal Society of Medicine higher mortality rate. Since then the operation has been refined, and is presently undertaken in two stages: results are now much more encouraging and it is thought that the 1986 figures will be comparable with those for the more traditional operation and suggestive of a better long-term prognosis.
The conclusion from this example, said Dr Shinebourne, is that we must indeed attempt innovative procedures, but there should be a limit on such procedures without their submission to an ethics committee: they ought to be part of a formal research protocol.
As a further example, he instanced a new development in the treatment of hypoplastic left-heart syndrome -the 1984 attempt to implant a baboon heart into a baby girl. No therapeutic result -i.e. no good -came of the procedure for that particular child; however, it may be seen as a first stage in a research programme from which future babies may benefit. As to who should decide what the risk/benefit equation represents in such a circumstance, he suggested that it should not essentially be either doctors or parents, and that an ethics committee is probably a better forum for such a decision than a court oflaw.
Professor V Dubowitz (Professor of Paediatrics, Hammersmith Hospital) endorsed many of Dr Shinebourne's remarks and amplified the subject by concentrating particularly on research procedures, often involving control groups, which are entirely non-therapeutic for the individual participant. The child, and more especially the neonate who cannot express any views, is a 'captive subject', like a prisoner or a mental patient, and therefore especial scrupulousness is required. He said that in his experience parents were often gratified by the idea that their child was helping in some way with research, and that where the child was old enough he or she could also participate in this concept.
Some research, for example that on growth and development, can only be done by using children, whereas other forms of research -for example, into blood levels and enzymes -may be better or more safely achieved by other means. It is, he pointed out, one thing to risk side effects with a new drug on a patient who is already suffering from a disease which the drug may eventually alleviate; it is another matter when the drug is to be tested on healthy children -though certain now-accepted and invaluable procedures, e.g, vaccination, could never have been established without being tried on healthy children at some stage. He stressed that children Or their parents should nevertheless always feel they have the right to refuse to be included in a research programme: the doctor should not become their adversary, and should beware of exerting moral pressure to participate where the child concerned has been successfully treated for another ailment. A written description of what is being asked may usefully be supplied, and time given to the family for refiection.
As for ethics committees, Dr Dubowitz pointed out that these can have a useful part to play in that they are or should be detached from any specific research interest. Such a committee can also take an overall review of the risks of research compared with the long-term risks to children in general of not having research: if the law on such matters were to become too stringent then many possible long-term benefits would be lost. He also touched briefly on research involving non-intervention -i.e. 'death as an option', especially relevant to badly damaged neonatesand on the recent contention about research using embryo tissue. He remarked that, contrary to the impression given in certain sections of the press, most of the embryo tissue used is at a very early stage of development. Results suggest that this is likely to be a fruitful line of research into genetic disorders, a field that is currently expanding.
Professor G Dworkin (Southampton University) then added a valuable amplification from his standpoint as a lawyer. 'Ethical' and 'permissible', he pointed out, are not necessarily the same. Under British law we have the concept of 'trespass' upon the body, which also opens up the question of voluntary and informed consent: in 1984 the House of Lords finally decided in favour of a plaintiff who contended that she had not been given sufficient information of the risk of a certain procedure to make an informed decision. Some countries, but not Britain, define matters more narrowly by saying that any operation 'must' be therapeutic in intent. In this country, on the other hand, it is within the power of the Courts to find some operations unlawful even where consent has been given -for example, the tattooing of a minor or female circumcision.
Addressing himselffurther to the vexed question of consent, Professor Dworkin remarked that in law the situation in which an adult gives consent to a procedure on a child is a delicate one, especially where innovative procedures are involved, and suggested that where the doctor departs from received medical opinion, much of the onus for the decision must shift to him. He also, like the other speakers, expressed the view that non-therapeutic research raises special problems of consent, and instanced the story of a Canadian student who 'consented' to participate, for a small fee, in what he thought would be a trivial drug trial, only to be permanently damaged by a cardiac arrest when a catheter was inserted under general anaesthesia: the Court eventually found that the doctor concerned had been guilty of a lack of full disclosure. As a general rule, except where very minor procedures are involved, consent to nontherapeutic research should be obtained with particular stringency; Professor Dworkin also made the point that the subject or his family have the right to change their mind at a later stage. He mentioned the Gillick case as raising an interesting problem concerning the age at which a child may be regarded as capable of giving legal consent in his or her own right, and was of the opinion that age is less crucial than the minor's capacity to understand.
A further interesting issue had been raised, he said, by the early kidney transplants which had been possible only between twins: the question then had been whether the parents could legally give proxy consent for the operation on the healthy twin. The matter was taken to Court in the US, where it was decided that were the healthy twin not to have his kidney removed for donation purposes, he might later suffer 'emotional disturbance' because his brother had been allowed to die when he could have saved him. Thus was the concept of the welfare of the child being paramount preserved? 'The welfare of the child' is always to be the first consideration-but this very phrase implies that other considerations may also be taken into account. In any case, immediate good and long-term good are not necessarily the same thing: the Lords had found, when a blood test on a child had been refused in a paternity case, that it was in fact in his best interests that he should undergo it. Taking all this into account, Professor Dworkin's conclusion was that the law may reasonably support a limited amount of non-therapeutic research on children -but he stressed 'limited'.
Subsequent general discussion centred on the most desirable composition of an ethics committee. It was generally felt that it should not be too big, nor be compounded entirely of doctors, and should in any Journal ofthe RoyalSocietyof Medicine Volume 80 May1987 323 event include a competent scientist, a moral philosopher and a nurse or other worker directly connected with administering the procedure, as well as a practitioner not concerned in the case. Suggestions from the floor that it should include 'a social worker', 'a lawyer' and 'an ordinary person' met with less than total agreement. Finally, on the issue of ultimate responsibility when matters go wrong, Professor Dworkin said that he would like to see established in this country the principle of compensation for injury regardless of negligence, and this met with general approval.
Gillian Tindall

Management of venous leg ulcers
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The symposium on management of the ulcerated limb, held at Northwick Park Hospital, Harrow, was the first of its kind between the Venous Forum ofthe Royal Society of Medicine and the Royal College of Nursing, and covered a number of important clinical issues affecting the care of patients with leg ulcers.
Each of the 15 speakers at the meeting advocated a switch to a scientifically based approach, with programmed diagnosis, early intervention, systematic treatment and follow up implemented by a well informed professional team of hospital and community doctors and nurses.
Critical evaluation of products based on hard data, not anecdotal evidence, was urged. It was suggested by Mr J Lewis that the Venous Forum could become influential in ensuring that appliances and dressings currently not prescribable on the drug tariff are made available in the community. This is crucial for consistent patient care.
Lipodermatosclerosis (LDS)
Mr K Burnand (St Thomas' Hospital, London) explained that there are three major factors in the aetiology of venous ulcers: first, superficial vein incompetence; secondly, incompetent perforators; and thirdly, post-phlebitic syndrome. Persistent venous hypertension, usually as a result of deep vein thrombosis, causes distension and elongation of the capillary loops. Molecules such as fibrinogen, which are normally intravascular, leak into the tissues. Defective fibrinolysis leads to the formation of pericapillary fibrin cuffs, which limit the diffusion of oxygen and other nutrients to the skin. The result is LDS, which Mr Burnand and others believe to be the precursor of venous ulceration. The importance of taking preventive measures to avoid venous ulceration was stressed.
Mr Burnand went on to discuss measures that can arrest progression from LDS to frank ulceration. Patients who present with pain, induration, a brown pigmentation and eczema in the gaiter area can benefit from a course of stanozolol (Stromba). This product, taken as 5 mg twice daily, stimulates fibrinolytic activity and thereby removes the fibrin cuffing which is thought to lead to venous ulceration. Below-knee graduated compression stockings are also effective, although not available in general practice. These, when combined with Stromba, have halved the healing time of LDS.
Importance ofaccurate diagnosis
Accurate diagnosis is the key to scientifically based treatment. In accordance with the need for a coordinated team approach, a medical and nursing assessment are of equal importance. Both were described by subsequent speakers. A 'commonsense' approach was described by Mr F Cockett (St Thomas' Hospital, London) in order, primarily, to make the initial and crucial distinction between arterial and venous ulcers. In an ageing population, the incidence of arterial disease will no dou bt increase. Mr Cockett warned that the presence of varicose veins does not rule out the possibility of arterial insufficiency as a cause of the ulcer.
If the patient has pigmentation in the gaiter area and dilated venules and capillaries round the heel and foot (ankle flare), then venous ulceration is most likely to occur. Absence of these two signs will also help to distinguish Marjolin's ulcers masquerading as venous ulcers, and decubitus ulcers on the malleolus. He also stated that the incompetent perforators may actually lie above or below the visibly bulging venule on the affected leg.
Examination of the back of the leg is important: short saphenous incompetence may be evident. Iliac vein or lymphatic obstruction should also be considered during examination of the thighs and abdomen.
Patients complaining of pain in the ulcerated leg either have an acute cellulitis, usually caused by Staph. aureus or anaerobic infection, or have ischaemia due to arterial involvement.
Regular measurements and serial drawings of ulcers were recommended by Mr J Dormandy (St James' Hospital, London) as an aid to scientific assessment. Mr Dormandy also suggested the use of a Doppler flow meter as a quantitative measure of arterial insufficiency.
The reliability of feeling for pedal pulse was questioned by Mr D Harper (Falkirk Royal Infirmary). The Royal Societyof Medicine
